As influenza activity increases in the US, health officials are urging widespread vaccination and the use of antiviral medications, particularly as a concerning new variant circulates and pediatric deaths reach record highs. The CDC is monitoring the H3N2 virus subclade K and has highlighted policy changes in vaccine recommendations. Last year’s flu season was exceptionally severe, with a high number of hospitalizations, especially among children, where vaccine effectiveness ranged from 63% to 78% in preventing hospitalization. Despite early indications suggesting the new variant could impact vaccine effectiveness, health officials emphasize vaccination remains critical.
Read More
A new COVID-19 variant, NB.1.8.1, is spreading in the U.S., though its presence is underreported on federal dashboards due to low case numbers. While currently less prevalent than LP.8.1, NB.1.8.1 has been detected in several states and is linked to increased hospitalizations in Asia. The World Health Organization classifies the global public health risk as low, but experts note its increased transmissibility compared to previous variants. Despite this, current COVID-19 vaccines are expected to remain effective against NB.1.8.1.
Read More
As someone who has personally experienced COVID-19, I understand the importance of vaccination and taking precautions to prevent infection. I contracted COVID-19 about a month ago, despite being fully vaccinated and boosted multiple times. Luckily, my symptoms were mild, consisting of lethargy and a low-grade fever for a night. However, what followed was unexpected – I caught the flu two weeks later. Even weeks after these illnesses, I still haven’t fully recovered. This experience emphasizes the importance of staying safe and taking necessary measures to protect ourselves and others.
The fact that the newest COVID shots are reported to be 54% effective in preventing symptomatic infections is actually quite encouraging.… Continue reading
John Q. Hosedrinker